Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy

BACKGROUND: Clinical studies have suggested that prostate health index (phi) outperforms prostate-specific antigen (PSA) tests in prostate cancer detection. The cost-effectiveness of phi with different cutoffs is poorly understood in the context of decision making for prostate biopsy. METHODS: In a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Oncol
Asıl Yazarlar: Huang, Da, Yang, Xiaoqun, Wu, Yishuo, Lin, Xiaoling, Xu, Danfeng, Na, Rong, Xu, Jianfeng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2020
Konular:
Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7732507/
https://ncbi.nlm.nih.gov/pubmed/33330035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.565382
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller